Inventor · disambiguated record
Douglas Alan Livingston
Also filed as: LIVINGSTON DOUGLAS A · LIVINGSTON DOUGLAS ALAN
23 granted patents·4 pending applications·660 citations·filing 1984–2008
97Inventor score
Files withJOLLA PHARMA9GLAXO WELLCOME INC5UPJOHN CO4SMITHKLINE BEECHAM CORP3LAJOLLA PHARMACEUTICAL COMPANY2
Top patents by PatentIndex Score
27 records- 0197US5552391AChemically-defined non-polymeric valency platform molecules and conjugates thereofJOLLA PHARMA·Filed 1993·Granted Sep 3, 1996·160 cites·12 claims
- 0295US4568741ASynthesis of 7-halo-7-deoxylincomycinsUPJOHN CO·Filed 1984·Granted Feb 4, 1986·60 cites·11 claims
- 0390US7351855B2Chemically defined non-polymeric valency platform molecules and conjugates thereofJOLLA PHARMA·Filed 2003·Granted Apr 1, 2008·24 cites·143 claims
- 0489US5606047AChemically-defined non-polymeric valency platform molecules and conjugates thereofJOLLA PHARMA·Filed 1995·Granted Feb 25, 1997·65 cites·1 claims
- 0585US5840990AIntermediates to carbocyclic nucleosidesGLAXO WELLCOME INC·Filed 1996·Granted Nov 24, 1998·18 cites·2 claims
- 0683US5726329AModified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotidesJOLLA PHARMA·Filed 1995·Granted Mar 10, 1998·53 cites·11 claims
- 0781US5641889ATherapeutic nucleosidesGLAXO WELLCOME INC·Filed 1993·Granted Jun 24, 1997·14 cites·4 claims
- 0880US6437124B1Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl) phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disordersSMITHKLINE BEECHAM CORP·Filed 2001·Granted Aug 20, 2002·11 cites·1 claims
- 0980US5633395AChemically-defined non-polymeric valency platform molecules and conjugates thereofJOLLA PHARMA·Filed 1995·Granted May 27, 1997·33 cites·1 claims
- 1080US4921638A17β-cyano-9α,17α-dihydroxyandrost-4-en-3-oneUPJOHN CO·Filed 1988·Granted May 1, 1990·25 cites·1 claims
- 1177US5391785AIntermediates for providing functional groups on the 5' end of oligonucleotidesJOLLA PHARMACEUTIAL COMPANY·Filed 1992·Granted Feb 21, 1995·32 cites·6 claims
- 1276US5874552AModified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotidesJOLLA PHARMA·Filed 1995·Granted Feb 23, 1999·29 cites·18 claims
- 1375US4977255ASteroidal 17α-silyl ethers and process to corticoids and progesteronesUPJOHN CO·Filed 1987·Granted Dec 11, 1990·24 cites·25 claims
- 1475US4710565AThesis of 7-halo-7-deoxylincomycinsUPJOHN CO·Filed 1986·Granted Dec 1, 1987·29 cites·15 claims
- 1574US5786512AModified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotidesLAJOLLA PHARMACEUTICAL COMPANY·Filed 1994·Granted Jul 28, 1998·24 cites·2 claims
- 1671US6392085B2Therapeutic nucleosidesSMITHKLINE BEECHAM CORP·Filed 1998·Granted May 21, 2002·7 cites·3 claims
- 1770US7115581B2Chemically-defined non-polymeric valency platform molecules and conjugates thereofJOLLA PHARMA·Filed 2002·Granted Oct 3, 2006·1 cites·46 claims
- 1868US5919941AIntermediates for the preparation of sulphonic acid salts of 4-amino-2-cyclopentene-1-carboxylic acidGLAXO WELLCOME INC·Filed 1997·Granted Jul 6, 1999·7 cites·3 claims
- 1965US5808147ATherapeutic nucleosidesGLAXO WELLCOME INC·Filed 1997·Granted Sep 15, 1998·13 cites·1 claims
- 2064US2008293660A1Chemically-defined non-polymeric valency platform molecules and conjugates thereofJOLLA PHARMA·Filed 2008·Application pending·0 cites
- 2162US6166198AMethods for oligonucleotide synthesisJOLLA PHARMA·Filed 1998·Granted Dec 26, 2000·12 cites·79 claims
- 2260US5856464ASelective capping solution phase oligonucleotide synthesisLAJOLLA PHARMACEUTICAL COMPANY·Filed 1995·Granted Jan 5, 1999·12 cites·16 claims
- 2360US2007254851A1Chemically-defined non-polymeric valency platform molecules and conjugates thereofCOUTTS STEPHEN M·Filed 2006·Application pending·0 cites
- 2456US2002082400A1Conjugates of T cell epitope deficient immunogen analogs for humoral anergy and chemically defined non-polymeric valency platform moleculesFiled 2000·Application pending·0 cites
- 2556US2002107389A1Conjugates of chemically defined non-polymeric valency platform molecules and biologically active moleculesFiled 2000·Application pending·0 cites
- 2653US7002012B2Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-YI)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disordersSMITHKLINE BEECHAM CORP·Filed 2002·Granted Feb 21, 2006·0 cites·2 claims
- 2752US6355646B1Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9H-purin-8-yl)phenyl derivatives, their preparation and their use in treatment of inflammatory conditions and immune disordersGLAXO WELLCOME INC·Filed 1998·Granted Mar 12, 2002·7 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Douglas Alan Livingston files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →